This year's conference focused on bridging data, policy, and patients in drug utilization research, bringing together experts and researchers from various fields to discuss the latest advancements in pharmacotherapy and drug safety.
During the conference, Anne Gerd delivered an oral communication titled “NOAC in Patients with Multidose Drug Dispensing: Drug Interactions, Concomitant Use of Anticholinergic or Fall Risk Increasing Drugs.” Her talk shed light on the complexities surrounding non-vitamin K antagonist oral anticoagulants (NOACs) and highlighted considerations for patient safety in those receiving multiple medications. This research is a collaboration with research partner Anne Katrine Eek at RELIS, Anette Vik Jøsendal at Apotek1, and former Master student in PharmaSafe, Ole Martin Søbakk.
Anne Gerd additionally presented the following Abstracts:
"Changes in prescribed medications after the introduction of an electronic prescribing system for patients with multidose drug dispensing."
"Improving the Cloud solution, Cassette, and Dispenser for an e-Dosette- a Design Thinking approach."
The conference featured a diverse program, with sessions that covered a broad range of topics in drug utilization research, showcasing innovative findings and promoting collaborative efforts among researchers, policymakers, and healthcare professionals.
For more details about the full program and speakers at EURODURG 2025, please visit the official program page.
We congratulate Anne Gerd on her important contribution to the conference and look forward to the continued impact of her research in the field of pharmacology and drug safety!